ONGLYZA® (saxagliptin) approved for use in Europe as combination therapy with insulin in adults with type 2 diabetes
28 November 2011 | By Bristol-Myers Squibb Company
The European Commission has approved ONGLYZA® (saxagliptin)...
List view / Grid view
28 November 2011 | By Bristol-Myers Squibb Company
The European Commission has approved ONGLYZA® (saxagliptin)...
28 November 2011 | By AstraZeneca
MedImmune Ventures closes investment in Australian company, NeuProtect Pty Ltd...
28 November 2011 | By Daniel J Edelman Ltd
The European Commission has granted marketing authorisation for EDURANT® (rilpivirine)...
28 November 2011 | By F T I Consulting
World’s leading researchers work together on therapeutic advances in neuroscience...
28 November 2011 | By Novartis
Rasitrio®, the first triple combination of aliskiren, amlodipine and hydrochlorothiazide in a single pill has received approval...
28 November 2011 | By Abbott
Abbott announced that it will expand its existing agreement with GSK...
28 November 2011 | By Gilead Sciences Inc
Gilead Sciences, Inc. announced that the European Commission has granted marketing authorization for Eviplera®...
23 November 2011 | By kdm communications limited
Syrris is pleased to announce the release of its new Asia flow chemistry reactors catalogue...
23 November 2011 | By Weizmann UK
The clinical trial was random, regulated, double-blinded and broad-based...
22 November 2011 | By Pfizer
Lead program includes novel investigational compound for prevention/treatment of skin scarring...
22 November 2011 | By H. Lundbeck A/S (Lundbeck)
H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) announced today that the US Food and Drug Administration (FDA) has determined that a new drug application (NDA) for Otsuka's investigational once-monthly aripiprazole depot formulation for the indication of maintenance treatment of schizophrenia in adults is sufficiently complete to permit…
22 November 2011 | By kdm communications limited
Donation of a Tecan Sunrise™ microplate reader to Mongolian medical researchers, assisting their studies of vitamin D levels in the general population...
22 November 2011 | By Merck
Merck has reached a resolution with federal and state authorities regarding a previously disclosed investigation concerning Vioxx...
21 November 2011 | By Pfizer
10-year lease marks a strategic partnership between the academic research community and industry to boost innovation...
21 November 2011 | By Gilead Sciences
Gilead Sciences, Inc., will acquire Pharmasset, Inc., for $137 per share in cash...